---
title: "Long Term Outcome in ICU Treated COVID-19: Return to Work"
nct_id: NCT05054608
overall_status: COMPLETED
sponsor: Uppsala University
study_type: OBSERVATIONAL
primary_condition: Covid19
countries: Sweden
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05054608.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05054608"
ct_last_update_post_date: 2022-12-05
last_seen_at: "2026-05-12T06:48:05.585Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Long Term Outcome in ICU Treated COVID-19: Return to Work

**NCT ID:** [NCT05054608](https://clinicaltrials.gov/study/NCT05054608)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 13537
- **Lead Sponsor:** Uppsala University
- **Collaborators:** Dalarna County Council, Sweden
- **Conditions:** Covid19
- **Start Date:** 2021-10-15
- **Completion Date:** 2021-11-15
- **CT.gov Last Update:** 2022-12-05

## Brief Summary

Return to work (not being on sick leave) within one year after intensive care unit (ICU) admission with Coronavirus disease 2019 (COVID-19) will be assessed. Risk and risk factors for not having returned to work will be compared to patients admitted to hospital and general population controls.

The ICU population comprises all Swedish ICU patients with COVID-19 with at least one year of follow up. The hospital admitted cohort comprises four hospital admitted patients with COVID-19 per ICU patient, matched on age, legal gender and region. The general population controls are matched to the ICU patients in a one to four fashion on age, legal gender and region.

ICU patients are identified in the Swedish intensive care registry. The hospital admitted patients are identified in the national patient registry and the population controls are identified in the population registry. Data on socioeconomics and income are provided by the Statistics Sweden. Data on comorbidity, medications and death are provided from the National board of health and welfare. Finally, data on sick leave are provided from the Swedish Social Insurance Agency.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 63 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

Admitted to a Swedish ICU and registered in the Swedish intensive care registry with the ICD 10 diagnosis U07.1 before 31 July 2020. ICU group.

or Admitted to hospital but not ICU with the ICD-10 diagnosis U07.1 in the national patient registry before 31 July 2020. Hospital group.

or randomly selected from the general population (and not included in the ICU or hospital admitted cohorts), matched on age, legal gender and region (four per ICU patient). Population control group

Exclusion Criteria:

Death within one year of inclusion. (For analysis of the secondary outcome). Missing a Swedish personal identification number
```

## Arms

- **COVID-19 ICU cohort** — All patients, 18 to 63 years old, admitted to a Swedish ICU with COVID-19 with at least one year of follow up. COVID-19 defined by the ICD-10 diagnosis U07.1 in the nationwide Swedish intensive care registry.
- **COVID-19 hospital admission control cohort** — Four random control patients per ICU patient matched on age legal gender and region. Controls selected from all patients admitted to a Swedish hospital with COVID-19 with at least one year of follow up. Not including patients in the COVID-19 ICU cohort. COVID-19 defined by the ICD-10 diagnosis U07.1 in the nationwide Swedish national patient registry.
- **General population control cohort** — Four general population controls per ICU patient, matched on age, legal gender and region drawn from the total population register of Sweden. Not including ICU and hospital admitted COVID-19 patients.

## Interventions

- **No intervention** (OTHER) — Observational study. No intervention.

## Primary Outcomes

- **Is group an independent risk factor for having one or more additional sick leave free days alive? Ordinal logistic model including variables below.** _(time frame: One year)_ — Variables in binary logistic model: On sick leave one year before ICU admission, Charlson comorbidity index, age, legal gender, highest education, immigrant background, income the year before inclusion, marital status, group (ICU, Hospital or General population).

## Secondary Outcomes

- **Is cohort an independent risk factor for being on sick leave one year after inclusion? Binary logistic model containing the variables below?** _(time frame: One year)_

## Locations (1)

- Uppsala University, Uppsala, Sweden

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.uppsala university|uppsala||sweden` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05054608.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05054608*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*